MRSA bacteraemia complicating amphotericin B treatment of cryptococcal meningitis
Intravenous amphotericin B is a key component of the antifungal therapy for cryptococcal meningitis recommended in South African and international guidelines. Unfortunately, its use is associated with significant toxicity including deterioration in renal function, electrolyte disturbance, anaemia an...
Main Authors: | J Scriven, J Cirota, C Viljoen, M Black, G Meintjes |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2013-09-01
|
Series: | Southern African Journal of HIV Medicine |
Subjects: | |
Online Access: | https://sajhivmed.org.za/index.php/hivmed/article/view/70 |
Similar Items
-
Case report: Reversible encephalopathy associated with liposomal amphotericin B in a patient with cryptococcal meningitis
by: Si Luo, et al.
Published: (2022-11-01) -
Clinical analysis of 26 cases with cryptococcal meningitis
by: Wei-wei HU, et al.
Published: (2014-08-01) -
Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
by: Nanfuka V, et al.
Published: (2021-09-01) -
Paradoxical respiratory failure due to cryptococcal pneumonia after amphotericin B treatment for HIV-associated cryptococcal meningitis
by: James E. Scriven, et al.
Published: (2018-03-01) -
Cryptococcal meningitis: An under-reported disease from the hills of Uttarakhand: A hospital-based cross-sectional study
by: Aroop Mohanty, et al.
Published: (2019-01-01)